Toward improved effectiveness of bladder cancer immunotherapy.
Departments of Surgery, Immunology, Bioengineering, Microbiology and Infectious Diseases, University of Pittsburgh, PA 15260, USA.|University of Pittsburgh Cancer Institute, Hillman Cancer Center, UPCI Research Pavilion Suite 1.46, 5117 Center Ave., Pittsburgh, PA 15213-1863, USA.
Pawel
P
Kalinski
University of Pittsburgh Cancer Institute, Hillman Cancer Center, UPCI Research Pavilion Suite 1.46, 5117 Center Ave., Pittsburgh, PA 15213-1863, USA.|Department of Urology, University of Pittsburgh, Pittsburgh, PA 15260, USA.
Jeffrey R
JR
Gingrich
D006801:Humans; D007167:Immunotherapy / Q000379:methods / Q000639:trends; D001749:Urinary Bladder Neoplasms / Q000276:immunology* / Q000628:therapy*
CTL; NK; bladder cancer; checkpoint blockade; chemokines; cytokines; dendritic cells; immunotherapy; interferons; microenvironment; natural killer; stroma; tumor